Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2007

01.11.2007 | Review Article

The Role of Smoking in Crohn’s Disease as Defined by Clinical Variables

verfasst von: Suhal S. Mahid, Kyle S. Minor, Patrick L. Stevens, Susan Galandiuk

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

The development of Crohn’s disease (CD) is related to an interaction of genetic and environmental factors, with tobacco smoking being one of the most commonly studied environmental factors. In 1998, the Vienna classification was created to define CD by using three accepted clinical variables: age at diagnosis, disease behavior, and disease location. In this qualitative systematic review, articles examining the relationship between smoking and CD, using variables outlined in the Vienna classification, were identified utilizing multiple health databases. Current smoking was found to be associated with late-onset CD (≥40 years old) and current smokers were more likely to progress to stricturing or penetrating type CD than were nonsmoking patients. Conflicting evidence exists regarding the relationship between smoking with respect to CD disease location. The Vienna classification is an important tool in permitting comparisons and predicting clinical course among CD cases, especially when smoking status is taken into account.
Literatur
1.
Zurück zum Zitat Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517PubMedCrossRef Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517PubMedCrossRef
2.
Zurück zum Zitat Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6(1):8–15PubMedCrossRef Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6(1):8–15PubMedCrossRef
3.
Zurück zum Zitat Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF (2005) Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54(3):357–363PubMedCrossRef Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF (2005) Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54(3):357–363PubMedCrossRef
4.
Zurück zum Zitat Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B (1988) Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 29(7):990–996PubMedCrossRef Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B (1988) Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 29(7):990–996PubMedCrossRef
5.
Zurück zum Zitat Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Di Paolo M, Riegler G, Rigo GP, Ferrau O, Mansi C, Ingrosso M, Valpiani D(1998) Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Int J Epidemiol 27(3):397–404PubMedCrossRef Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Di Paolo M, Riegler G, Rigo GP, Ferrau O, Mansi C, Ingrosso M, Valpiani D(1998) Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Int J Epidemiol 27(3):397–404PubMedCrossRef
6.
Zurück zum Zitat Somerville KW, Logan RF, Edmond M, Langman MJ (1984) Smoking and Crohn’s disease. Br Med J (Clin Res Ed) 289(6450):954–956 Somerville KW, Logan RF, Edmond M, Langman MJ (1984) Smoking and Crohn’s disease. Br Med J (Clin Res Ed) 289(6450):954–956
7.
Zurück zum Zitat Tobin MV, Logan RF, Langman MJ, McConnell RB, Gilmore IT (1989) Cigarette smoking and inflammatory bowel disease. Gastroenterology 93(2):316–321 Tobin MV, Logan RF, Langman MJ, McConnell RB, Gilmore IT (1989) Cigarette smoking and inflammatory bowel disease. Gastroenterology 93(2):316–321
8.
Zurück zum Zitat Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB (1989) Cigarette smoking in Crohn’s disease. Am J Gastroenterol 84(1):31–33PubMed Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB (1989) Cigarette smoking in Crohn’s disease. Am J Gastroenterol 84(1):31–33PubMed
9.
Zurück zum Zitat Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA (2005) Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 22(4):309–315PubMedCrossRef Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA (2005) Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 22(4):309–315PubMedCrossRef
10.
Zurück zum Zitat Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34(12):1841–1854PubMedCrossRef Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34(12):1841–1854PubMedCrossRef
11.
Zurück zum Zitat Farmer RG, Hawk WA, Turnbull RB Jr (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68:627–635PubMed Farmer RG, Hawk WA, Turnbull RB Jr (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68:627–635PubMed
12.
Zurück zum Zitat Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S (2005) Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 11(1):42–47PubMedCrossRef Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S (2005) Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 11(1):42–47PubMedCrossRef
13.
Zurück zum Zitat Lashner BA, Shaheen NJ, Hanauer SB, Kirschner BS (1993) Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol 88(3):356–359PubMed Lashner BA, Shaheen NJ, Hanauer SB, Kirschner BS (1993) Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol 88(3):356–359PubMed
14.
Zurück zum Zitat Persson PG, Ahlbom A, Hellers G (1990) Inflammatory bowel disease and tobacco smoke- a case-control study. Gut 31(12):1377–1381PubMedCrossRef Persson PG, Ahlbom A, Hellers G (1990) Inflammatory bowel disease and tobacco smoke- a case-control study. Gut 31(12):1377–1381PubMedCrossRef
15.
Zurück zum Zitat Franceschi S, Panza E, La Vecchia C, Parazzini F, Decarli A, Bianchi PG (1987) Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 125(3):445–452PubMed Franceschi S, Panza E, La Vecchia C, Parazzini F, Decarli A, Bianchi PG (1987) Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 125(3):445–452PubMed
16.
Zurück zum Zitat Aldhous MC, Drummond HE, Arnott DR, Smith L, Satsangi J (2005) Effect of smoking habit and load on clinical presentation and progression in Crohn’s disease and ulcerative colitis. BSG Abstracts, A2 Aldhous MC, Drummond HE, Arnott DR, Smith L, Satsangi J (2005) Effect of smoking habit and load on clinical presentation and progression in Crohn’s disease and ulcerative colitis. BSG Abstracts, A2
17.
Zurück zum Zitat Bustamante M, Nos P, Hoyos M, Hinojosa J, Moles JR, Garcia-Herola A, Berenguer J (1998) Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig 90(12):833–840PubMed Bustamante M, Nos P, Hoyos M, Hinojosa J, Moles JR, Garcia-Herola A, Berenguer J (1998) Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig 90(12):833–840PubMed
18.
Zurück zum Zitat Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, Stockbrugger RW (1998) Inflammatory bowel disease: Is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 4:182–186PubMedCrossRef Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, Stockbrugger RW (1998) Inflammatory bowel disease: Is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 4:182–186PubMedCrossRef
19.
Zurück zum Zitat Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP (1996) Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 110(2):424–431PubMedCrossRef Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP (1996) Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 110(2):424–431PubMedCrossRef
20.
Zurück zum Zitat Lindberg E, Jarnerot G, Huitfeldt B (1992) Smoking in Crohn’s disease: effect on localisation and clinical course. Gut 33(6):779–782PubMedCrossRef Lindberg E, Jarnerot G, Huitfeldt B (1992) Smoking in Crohn’s disease: effect on localisation and clinical course. Gut 33(6):779–782PubMedCrossRef
21.
Zurück zum Zitat Benoni C, Nilsson A (1984) Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 19(6):824–830PubMed Benoni C, Nilsson A (1984) Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 19(6):824–830PubMed
22.
Zurück zum Zitat Holdstock G, Savage D, Harman M, Wright R (1984) Should patients with inflammatory bowel disease smoke? Br Med J (Clin Res Ed) 288(6414):362CrossRef Holdstock G, Savage D, Harman M, Wright R (1984) Should patients with inflammatory bowel disease smoke? Br Med J (Clin Res Ed) 288(6414):362CrossRef
23.
Zurück zum Zitat Picco MF, Bayless TM (2003) Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn’s disease. Am J Gastroenterol 98(2):363–368PubMedCrossRef Picco MF, Bayless TM (2003) Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn’s disease. Am J Gastroenterol 98(2):363–368PubMedCrossRef
24.
Zurück zum Zitat Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J (2003) Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52(4):552–557PubMedCrossRef Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J (2003) Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52(4):552–557PubMedCrossRef
25.
Zurück zum Zitat Lautenbach E, Berlin JA, Lichtenstein GR (1998) Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology 115(2):259–267PubMedCrossRef Lautenbach E, Berlin JA, Lichtenstein GR (1998) Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology 115(2):259–267PubMedCrossRef
26.
Zurück zum Zitat Rocca G, Astegiano M, Sostegni R, Fiorentini MT, Musso A, Bresso F, Greco S, Ponti V, Demarchi B, Rizzetto M, Pera A (1997) Effect of current smoking on the clinical presentation, medical therapy, and surgical therapy of Crohn’s disease. Gastroenterology 112:A1074 Rocca G, Astegiano M, Sostegni R, Fiorentini MT, Musso A, Bresso F, Greco S, Ponti V, Demarchi B, Rizzetto M, Pera A (1997) Effect of current smoking on the clinical presentation, medical therapy, and surgical therapy of Crohn’s disease. Gastroenterology 112:A1074
27.
Zurück zum Zitat Breuer-Katschinski BD, Hollander N, Goebell H (1996) Effect of cigarette smoking on the course of Crohn’s disease. Eur J Gastroenterol Hepatol 8(3):225–228PubMedCrossRef Breuer-Katschinski BD, Hollander N, Goebell H (1996) Effect of cigarette smoking on the course of Crohn’s disease. Eur J Gastroenterol Hepatol 8(3):225–228PubMedCrossRef
28.
Zurück zum Zitat Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250PubMedCrossRef Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250PubMedCrossRef
29.
Zurück zum Zitat Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49(6):777–782PubMedCrossRef Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49(6):777–782PubMedCrossRef
30.
Zurück zum Zitat Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 231(1): 38–45PubMedCrossRef Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 231(1): 38–45PubMedCrossRef
31.
Zurück zum Zitat Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH Jr (1988) Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 29(5):588–592PubMedCrossRef Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH Jr (1988) Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 29(5):588–592PubMedCrossRef
32.
Zurück zum Zitat Sachar DB, Andrews HA, Farmer RG, Pallone F, Pena AS, Prantera C, Rutgeerts P (1992) Proposed classification of patient subgroups in Crohn’s disease. Gastroenterol Int 5:141–154 Sachar DB, Andrews HA, Farmer RG, Pallone F, Pena AS, Prantera C, Rutgeerts P (1992) Proposed classification of patient subgroups in Crohn’s disease. Gastroenterol Int 5:141–154
33.
Zurück zum Zitat Ekbom A, Helmick C, Zack M, Adami HO (1991) The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 100(2):350–358PubMed Ekbom A, Helmick C, Zack M, Adami HO (1991) The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 100(2):350–358PubMed
34.
Zurück zum Zitat Devlin HB, Datta D, Dellipiani AW (1980) The incidence and prevalence of inflammatory bowel disease in North Tees Health District. World J Surg 4(2):183–193PubMedCrossRef Devlin HB, Datta D, Dellipiani AW (1980) The incidence and prevalence of inflammatory bowel disease in North Tees Health District. World J Surg 4(2):183–193PubMedCrossRef
35.
Zurück zum Zitat Lee FI, Costello FT (1985) Crohn’s disease in Blackpool—incidence and prevalence 1968–80. Gut 26(3):274–278PubMedCrossRef Lee FI, Costello FT (1985) Crohn’s disease in Blackpool—incidence and prevalence 1968–80. Gut 26(3):274–278PubMedCrossRef
36.
Zurück zum Zitat Freeman HJ (2005) Age-dependant phenotypic clinical expression of Crohn’s disease. J Clin Gastroenterol 39(9):774–777PubMedCrossRef Freeman HJ (2005) Age-dependant phenotypic clinical expression of Crohn’s disease. J Clin Gastroenterol 39(9):774–777PubMedCrossRef
37.
Zurück zum Zitat Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM (1996) Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111(3):580–586PubMedCrossRef Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM (1996) Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111(3):580–586PubMedCrossRef
38.
Zurück zum Zitat Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH (2003) Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis 9(5):281–289PubMedCrossRef Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH (2003) Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis 9(5):281–289PubMedCrossRef
39.
Zurück zum Zitat Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP, EPWG-IBD Group, EPIMAD Group, GETAID Group (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70(4):845–857PubMedCrossRef Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP, EPWG-IBD Group, EPIMAD Group, GETAID Group (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70(4):845–857PubMedCrossRef
40.
Zurück zum Zitat CDC (2004) State-specific prevalance of current cigarette smoking among adults: United States, 2003. MMWR 53:1035–1037 CDC (2004) State-specific prevalance of current cigarette smoking among adults: United States, 2003. MMWR 53:1035–1037
41.
Zurück zum Zitat Jewell T, Robeson S (2004) Smoking during pregnancy: update continuing to place Kentucky’s children at risk. Kentucky Epidemiol NotesRep 39(Nov):1–6 Jewell T, Robeson S (2004) Smoking during pregnancy: update continuing to place Kentucky’s children at risk. Kentucky Epidemiol NotesRep 39(Nov):1–6
42.
Zurück zum Zitat Mahid SS, Minor KS, Stromberg A, Galandiuk S (in press) Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis Mahid SS, Minor KS, Stromberg A, Galandiuk S (in press) Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis
43.
Zurück zum Zitat Veloso FT, Ferreira JT, Barros L, Almeida S (2001) Clinical outcome of Crohn’s disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 7(4):306–313PubMedCrossRef Veloso FT, Ferreira JT, Barros L, Almeida S (2001) Clinical outcome of Crohn’s disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 7(4):306–313PubMedCrossRef
44.
Zurück zum Zitat Present DH (2005) Management of fistula disease. Inflamm Bowel Dis 4:302–307CrossRef Present DH (2005) Management of fistula disease. Inflamm Bowel Dis 4:302–307CrossRef
Metadaten
Titel
The Role of Smoking in Crohn’s Disease as Defined by Clinical Variables
verfasst von
Suhal S. Mahid
Kyle S. Minor
Patrick L. Stevens
Susan Galandiuk
Publikationsdatum
01.11.2007
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2007
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9624-0

Weitere Artikel der Ausgabe 11/2007

Digestive Diseases and Sciences 11/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.